Literature DB >> 10346909

The interaction between rac1 and its guanine nucleotide dissociation inhibitor (GDI), monitored by a single fluorescent coumarin attached to GDI.

A R Newcombe1, R W Stockley, J L Hunter, M R Webb.   

Abstract

The interaction of rac with guanine nucleotide dissociation inhibitor protein (rhoGDI) is described, using GDI fluorescently labeled on its single cysteine with N-[2-(1-maleimidyl)ethyl]-7-diethylaminocoumarin-3-carboxamide (MDCC). The labeled GDI shows a 70% decrease in fluorescence emission on binding geranylgeranylated rac1.GDP and has an affinity for rac1 within a factor of 2 of the unlabeled GDI. The labeled GDI was used to determine the kinetic mechanism of the interaction by measuring the association and dissociation in real time. The kinetics are interpreted in terms of a two-step mechanism: binding of rac to GDI and then a conformational change of the complex with an overall dissociation constant of 0.4 nM. The conformational change has a rate constant of 7.3 s-1 (pH 7.5, 30 degrees C), and the reverse has a rate constant of 1.4 x 10(-)3 s-1. To overcome difficulties inherent in using and manipulating lipid-modified rac, we also used a combination of unmodified rac1, expressed in Escherichia coli and produced with C-terminal truncation (thus lacking the cysteine that is the site of lipid attachment), and farnesylated C-terminal peptide. This combination can mimic geranylgeranylated rac1, producing a complex with the coumarin-labeled GDI, and was used to examine the relative importance of different regions of rac1 in interaction with GDI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346909     DOI: 10.1021/bi9829837

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes.

Authors:  Marie-Annick Forget; Richard R Desrosiers; Denis Gingras; Richard Béliveau
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

2.  Semaphorin 5A and plexin-B3 inhibit human glioma cell motility through RhoGDIalpha-mediated inactivation of Rac1 GTPase.

Authors:  Xinhua Li; Alan Yiu Wah Lee
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

3.  Interaction of anesthetics with the Rho GTPase regulator Rho GDP dissociation inhibitor.

Authors:  Cojen Ho; Sivananthaperumal Shanmugasundararaj; Keith W Miller; Steve A Malinowski; Anthony C Cook; Simon J Slater
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

4.  Fluorescence detection of GDP in real time with the reagentless biosensor rhodamine-ParM.

Authors:  Simone Kunzelmann; Martin R Webb
Journal:  Biochem J       Date:  2011-11-15       Impact factor: 3.857

5.  Electrostatic Forces Mediate the Specificity of RHO GTPase-GDI Interactions.

Authors:  Niloufar Mosaddeghzadeh; Neda S Kazemein Jasemi; Jisca Majolée; Si-Cai Zhang; Peter L Hordijk; Radovan Dvorsky; Mohammad Reza Ahmadian
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

6.  The Pseudo-Natural Product Rhonin Targets RHOGDI.

Authors:  Mohammad Akbarzadeh; Jana Flegel; Sumersing Patil; Erchang Shang; Rishikesh Narayan; Marcel Buchholzer; Neda S Kazemein Jasemi; Michael Grigalunas; Adrian Krzyzanowski; Daniel Abegg; Anton Shuster; Marco Potowski; Hacer Karatas; George Karageorgis; Niloufar Mosaddeghzadeh; Mia-Lisa Zischinsky; Christian Merten; Christopher Golz; Lucas Brieger; Carsten Strohmann; Andrey P Antonchick; Petra Janning; Alexander Adibekian; Roger S Goody; Mohammad Reza Ahmadian; Slava Ziegler; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-02       Impact factor: 16.823

7.  Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells.

Authors:  Beatrix Hage; Katrin Meinel; Iris Baum; Klaudia Giehl; Andre Menke
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.